wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34026441-1CAAA152-E2D6-4EF5-9E1B-34F55F4618AB
Q34026441-1CAAA152-E2D6-4EF5-9E1B-34F55F4618AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34026441-1CAAA152-E2D6-4EF5-9E1B-34F55F4618AB
Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.
P2860
Q34026441-1CAAA152-E2D6-4EF5-9E1B-34F55F4618AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34026441-1CAAA152-E2D6-4EF5-9E1B-34F55F4618AB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c199133ff7140263f638b6eaa1443f4799fd35d7
P2860
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.